Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022

被引:0
|
作者
Surie, Diya [1 ]
Bonnell, Levi [1 ]
Adams, Katherine [1 ]
Gaglani, Manjusha [2 ,3 ]
Ginde, Adit A. [4 ]
Douin, David J. [4 ]
Talbot, H. Keipp [5 ]
Casey, Jonathan D. [5 ]
Mohr, Nicholas M. [6 ]
Zepeski, Anne [6 ]
McNeal, Tresa [3 ,4 ]
Ghamande, Shekhar [3 ,4 ]
Gibbs, Kevin W. [7 ]
Files, D. Clark [7 ]
Hager, David N. [8 ]
Shehu, Arber [8 ]
Frosch, Anne P. [9 ]
Erickson, Heidi L. [9 ]
Gong, Michelle N. [10 ]
Mohamed, Amira [10 ]
Johnson, Nicholas J. [11 ]
Srinivasan, Vasisht [11 ]
Steingrub, Jay S. [12 ]
Peltan, Ithan D. [13 ]
Brown, Samuel M. [13 ]
Martin, Emily T. [14 ]
Khan, Akram [15 ]
Bender, William S. [16 ]
Duggal, Abhijit [17 ]
Wilson, Jennifer G. [18 ]
Qadir, Nida [19 ]
Chang, Steven Y. [19 ]
Mallow, Christopher [20 ]
Rivas, Carolina [20 ]
Kwon, Jennie H. [21 ]
Exline, Matthew C. [22 ]
Lauring, Adam S. [23 ]
Shapiro, Nathan I. [24 ]
Halasa, Natasha [5 ]
Chappell, James D. [5 ]
Grijalva, Carlos G. [5 ]
Rice, Todd W. [5 ]
Stubblefield, William B. [5 ]
Baughman, Adrienne [5 ]
Womack, Kelsey N. [5 ]
Hart, Kimberly W. [5 ]
Swan, Sydney A. [5 ]
Zhu, Yuwei [5 ]
DeCuir, Jennifer [1 ]
Tenforde, Mark W. [1 ]
机构
[1] CDC COVID 19 Emergency Response Team, Atlanta, GA 30329 USA
[2] Baylor Scott & White Hlth, Temple, TX USA
[3] Texas A&M Univ, Coll Med, Temple, TX USA
[4] Univ Colorado, Sch Med, Aurora, CO USA
[5] Vanderbilt Univ Sch Med, Nashville, TN USA
[6] Univ Iowa, Iowa City, IA USA
[7] Wake Forest Univ, Baptist Med Ctr, Winston Salem, NC USA
[8] Johns Hopkins Univ Hosp, Baltimore, MD USA
[9] Hennepin Cty Med Ctr, Minneapolis, MN USA
[10] Albert Einstein Coll Med, Montefiore Healthcare Ctr, New York, NY USA
[11] Univ Washington, Sch Med, Seattle, WA USA
[12] Baystate Med Ctr, Springfield, MA USA
[13] Univ Utah, Intermt Med Ctr, Salt Lake City, UT USA
[14] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI USA
[15] Oregon Hlth & Sci Univ Hosp, Portland, OR USA
[16] Emory Univ, Sch Med, Atlanta, GA USA
[17] Cleveland Clin, Cleveland, OH USA
[18] Stanford Univ, Sch Med, Stanford, CA USA
[19] Ronald Reagan UCLAMed Ctr, Los Angeles, CA USA
[20] Univ Miami, Miami, FL USA
[21] Washington Univ, St Louis, MO USA
[22] Ohio State Univ, Wexner Med Ctr, Columbus, OH USA
[23] Univ Michigan, Sch Med, Ann Arbor, MI USA
[24] Beth Israel Deaconess Med Ctr, Boston, MA USA
来源
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:1327 / 1334
页数:8
相关论文
共 46 条
  • [1] Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
    Tseng, Hung Fu
    Ackerson, Bradley K.
    Bruxvoort, Katia J.
    Sy, Lina S.
    Tubert, Julia E.
    Lee, Gina S.
    Ku, Jennifer H.
    Florea, Ana
    Luo, Yi
    Qiu, Sijia
    Choi, Soon Kyu
    Takhar, Harpreet S.
    Aragones, Michael
    Paila, Yamuna D.
    Chavers, Scott
    Talarico, Carla A.
    Qian, Lei
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [2] Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
    Hung Fu Tseng
    Bradley K. Ackerson
    Katia J. Bruxvoort
    Lina S. Sy
    Julia E. Tubert
    Gina S. Lee
    Jennifer H. Ku
    Ana Florea
    Yi Luo
    Sijia Qiu
    Soon Kyu Choi
    Harpreet S. Takhar
    Michael Aragones
    Yamuna D. Paila
    Scott Chavers
    Carla A. Talarico
    Lei Qian
    Nature Communications, 14
  • [3] Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022
    Link-Gelles, Ruth
    Levy, Matthew E.
    Gaglani, Manjusha
    Irving, Stephanie A.
    Stockwell, Melissa
    Dascomb, Kristin
    DeSilva, Malini B.
    Reese, Sarah E.
    Liao, I-Chia
    Ong, Toan C.
    Grannis, Shaun J.
    McEvoy, Charlene
    Patel, Palak
    Klein, Nicola P.
    Hartmann, Emily
    Stenehjem, Edward
    Natarajan, Karthik
    Naleway, Allison L.
    Murthy, Kempapura
    Rao, Suchitra
    Dixon, Brian E.
    Kharbanda, Anupam B.
    Akinseye, Akintunde
    Dickerson, Monica
    Lewis, Ned
    Grisel, Nancy
    Han, Jungmi
    Barron, Michelle A.
    Fadel, William F.
    Dunne, Margaret M.
    Goddard, Kristin
    Arndorfer, Julie
    Konatham, Deepika
    Valvi, Nimish R.
    Currey, J. C.
    Fireman, Bruce
    Raiyani, Chandni
    Zerbo, Ousseny
    Sloan-Aagard, Chantel
    Ball, Sarah W.
    Thompson, Mark G.
    Tenforde, Mark W.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (29): : 931 - 939
  • [4] A broadly neutralizing antibody against the SARS-CoV-2 Omicron sub-variants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
    Chen, Zhe
    Feng, Leilei
    Wang, Lei
    Zhang, Li
    Zheng, Binyang
    Fu, Hua
    Li, Fengdi
    Liu, Ligai
    Lv, Qi
    Deng, Ran
    Xu, Yanli
    Hu, Yongfeng
    Zheng, Jianhua
    Qin, Chuan
    Bao, Linlin
    Wang, Xiangxi
    Jin, Qi
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2025, 10 (01)
  • [5] Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim results
    Chalkias, Spyros
    Whatley, Jordan L.
    Eder, Frank
    Essink, Brandon
    Khetan, Shishir
    Bradley, Paul
    Brosz, Adam
    Mcghee, Nichole
    Tomassini, Joanne E.
    Chen, Xing
    Zhao, Xiaoping
    Sutherland, Andrea
    Shen, Xiaoying
    Girard, Bethany
    Edwards, Darin K.
    Feng, Jing
    Zhou, Honghong
    Walsh, Stephen
    Montefiori, David C.
    Baden, Lindsey R.
    Miller, Jacqueline M.
    Das, Rituparna
    NATURE MEDICINE, 2023, 29 (9) : 2325 - 2333
  • [6] Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim results
    Spyros Chalkias
    Jordan L. Whatley
    Frank Eder
    Brandon Essink
    Shishir Khetan
    Paul Bradley
    Adam Brosz
    Nichole McGhee
    Joanne E. Tomassini
    Xing Chen
    Xiaoping Zhao
    Andrea Sutherland
    Xiaoying Shen
    Bethany Girard
    Darin K. Edwards
    Jing Feng
    Honghong Zhou
    Stephen Walsh
    David C. Montefiori
    Lindsey R. Baden
    Jacqueline M. Miller
    Rituparna Das
    Nature Medicine, 2023, 29 : 2325 - 2333
  • [7] Effectiveness of Booster Doses of Monovalent mRNA COVID-19 Vaccine Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children, Adolescents, and Adults During Omicron Subvariant BA.2/BA.2.12.1 and BA.4/BA.5 Predominant Periods
    Ciesla, Allison Avrich
    Wiegand, Ryan E.
    Smith, Zachary R.
    Britton, Amadea
    Fleming-Dutra, Katherine E.
    Miller, Joseph
    Accorsi, Emma K.
    Verani, Jennifer R.
    Shang, Nong
    Derado, Gordana
    Pilishvili, Tamara
    Link-Gelles, Ruth
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (05):
  • [8] SARS-CoV-2 Omicron (BA.4, BA.5) variant: Lessons learned from a new variant during the COVID-19 pandemic
    Erabi, Gisou
    Faridzadeh, Arezoo
    Parvin, Ali
    Deravi, Niloofar
    Rahmanian, Mohammad
    Fathi, Mobina
    Aleebrahim-Dehkordi, Elahe
    Rezaei, Nima
    HEALTH SCIENCE REPORTS, 2024, 7 (02)
  • [9] 19n01, a broadly neutralizing antibody against omicron BA.1, BA.2, BA.4/5, and other SARS-CoV-2 variants of concern
    Garcia-Vega, Melissa
    Melgoza-Gonzalez, Edgar A.
    Hernandez-Valenzuela, Sofia
    Hinojosa-Trujillo, Diana
    Resendiz-Sandoval, Monica
    Llamas-Covarrubias, Mara Anais
    Loza-Lopez, Martin
    Valenzuela, Olivia
    Soto-Gaxiola, Alan
    Hernandez-Onate, Miguel A.
    Mata-Haro, Veronica
    Cassaniti, Irene
    Sammartino, Jose Camilla
    Ferrari, Alessandro
    Simonelli, Luca
    Pedotti, Mattia
    Sun, Rui
    Zuo, Fanglei
    Baldanti, Fausto
    Varani, Luca
    Marcotte, Harold
    Pan-Hammarstrom, Qiang
    Hernandez, Jesus
    ISCIENCE, 2023, 26 (04)
  • [10] Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022
    Britton, Amadea
    Embi, Peter J.
    Levy, Matthew E.
    Gaglani, Manjusha
    DeSilva, Malini B.
    Dixon, Brian E.
    Dascomb, Kristin
    Patel, Palak
    Schrader, Kristin E.
    Klein, Nicola P.
    Ong, Toan C.
    Natarajan, Karthik
    Hartmann, Emily
    Kharbanda, Anupam B.
    Irving, Stephanie A.
    Dickerson, Monica
    Dunne, Margaret M.
    Raiyani, Chandni
    Grannis, Shaun J.
    Stenehjem, Edward
    Zerbo, Ousseny
    Rao, Suchitra
    Han, Jungmi
    Sloan-Aagard, Chantel
    Griggs, Eric P.
    Weber, Zachary A.
    Murthy, Kempapura
    Fadel, William F.
    Grisel, Nancy
    McEvoy, Charlene
    Lewis, Ned
    Barron, Michelle A.
    Nanez, Juan
    Reese, Sarah E.
    Mamawala, Mufaddal
    Valvi, Nimish R.
    Arndorfer, Julie
    Goddard, Kristin
    Yang, Duck-Hye
    Fireman, Bruce
    Ball, Sarah W.
    Link-Gelles, Ruth
    Naleway, Allison L.
    Tenforde, Mark W.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (42): : 1335 - 1342